About Seqera Labs
Seqera Labs is a company based in Barcelona (Spain) founded in 2018 by Paolo Di Tommaso and Evan Floden. Seqera Labs has raised $27.18 million across 3 funding rounds from investors including The Chan Zuckerberg Initiative, Speedinvest and Addition Capital. Seqera Labs offers products and services including Seqera Platform and Nextflow. Seqera Labs operates in a competitive market with competitors including Benchling, Curoverse, Scispot, Vyasa and Academix, among others.
- Headquarter Barcelona, Spain
- Founders Paolo Di Tommaso, Evan Floden
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$27.18 M (USD)
in 3 rounds
-
Latest Funding Round
$21.68 M (USD), Series A
Oct 25, 2022
-
Investors
The Chan Zuckerberg Initiative
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Seqera Labs
Seqera Labs offers a comprehensive portfolio of products and services, including Seqera Platform and Nextflow.
Platform for centralizing data and streamlining pipelines in research
Enables scalable and reproducible scientific workflows using containers
People of Seqera Labs
Unlock access to complete
Funding Insights of Seqera Labs
Seqera Labs has successfully raised a total of $27.18M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $21.68 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Seqera Labs
Seqera Labs has secured backing from 8 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include The Chan Zuckerberg Initiative, Speedinvest and Addition Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity fund focused on multiple sectors
|
Locked | Locked | Locked | |
|
Venture capital fund investing in tech startups
|
Locked | Locked | Locked | |
|
Early-stage venture capital and startup acceleration are provided.
|
Locked | Locked | Locked |
Investor details for Seqera Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Seqera Labs
Investment portfolio details for Seqera Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Seqera Labs
Detailed financials for Seqera Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Seqera Labs Comparisons
Peer comparison for Seqera Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Seqera Labs
Seqera Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Benchling, Curoverse, Scispot, Vyasa and Academix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
Genomic and biomedical Big Data infrastructure is provided.
|
|
| Locked | Locked | Locked |
Provider of a cloud platform for laboratory data and workflow management
|
|
| Locked | Locked | Locked |
Deep learning platform is provided for life sciences market research.
|
|
| Locked | Locked | Locked |
Research partners are matched via AI on an online platform.
|
Detailed competitors of Seqera Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Seqera Labs
Complete news archive for Seqera Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Seqera Labs
Seqera Labs was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Seqera Labs is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Evan Floden is the current CEO of Seqera Labs. They have also founded this company.
Seqera Labs is a funded company, having raised a total of $27.18M across 3 funding rounds to date.
Provider of a bioinformatics platform for scientific data analysis and workflow management. The platform centralizes data, streamlines pipelines, and manages infrastructure within a secure environment. It integrates with existing on-premises systems and cloud platforms, maintaining control over data residency. The platform offers a unified environment for high-throughput, cost-effective computation, suitable for genomics and AI-based drug discovery. It facilitates collaboration between teams through an intuitive interface and secure APIs, ensuring reproducible workflows and auditability.
Seqera Labs's top competitors include Benchling, Curoverse and Infonetica.
Seqera Labs offers Seqera Platform and Nextflow.
Seqera Labs has 8 investors. Key investors include The Chan Zuckerberg Initiative, Speedinvest, Addition Capital, Talis Capital, and Amino Collective.